Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Weissfeld JL, Fagerstrom RM, O'Brien B; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):390S-399S.

PMID:
11189690
2.

The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.

Gohagan JK, Prorok PC, Greenwald P, Kramer BS.

Rev Recent Clin Trials. 2015;10(3):173-80. Review.

PMID:
26238115
3.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
4.

Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center.

Gren LH, Lamerato LE, Wright P, Marcus PM.

Rev Recent Clin Trials. 2015;10(3):194-9. Review.

PMID:
26238206
5.

Building Successful Relationships in the PLCO Cancer Screening Trial.

Marcus PM, Broski KG, Buys SS, Childs J, Church TR, Gohagan JK, Gren LH, Higgins D, Jaggi R, Jenkins V, Johnson CC, Lappe K, O'Brien B, Ogden SL, Prorok PC, Reding D, Shambaugh V, Yokochi LA, Yurgalevitch S.

Rev Recent Clin Trials. 2015;10(3):181-6. Review.

PMID:
26238208
6.

Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.

Gohagan JK, Broski K, Gren LH, Fouad MN, Higgins D, Lappe K, Ogden S, Shambaugh V, Pinsky PF, O'Brien B, Yurgalevich S, Riley T, Wright P, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):187-93. Review.

PMID:
26435288
7.

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK.

J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. Review.

8.

Data Processing and Analytic Support in the PLCO Cancer Screening Trial.

Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):233-7. Review.

PMID:
26238116
9.

Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial.

Miller AB, Madalinska JB, Church T, Crawford D, Essink-Bot ML, Goel V, de Koning HJ, Määttänen L, Pentikäinen T.

Eur J Cancer. 2001 Nov;37(17):2154-60. Review.

PMID:
11677101
10.

Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial.

Bazzi L, Lamerato LE, Varner J, Shambaugh VL, Cordes JE, Ragard LR, Marcus PM.

Rev Recent Clin Trials. 2015;10(3):200-5. Review.

PMID:
26238207
11.

The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource.

Carrick DM, Black A, Gohagan JK, Khan A, Pettit K, Williams C, Yu K, Yurgalevitch S, Huang WY, Zhu C.

Rev Recent Clin Trials. 2015;10(3):212-22. Review.

PMID:
26238117
12.

Screening for cancer: future potential.

Cuzick J.

Eur J Cancer. 1999 Dec;35(14):1925-32. Review.

PMID:
10711235
13.

[Early detection of cancer of the prostate. Pros and cons].

Hoesl CE, Altwein JE.

MMW Fortschr Med. 2005 Apr 7;147(14):32, 34-6. Review. German.

PMID:
15887681
14.

Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Lawrence W Jr, Miller A, ProroK PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P.

Rev Recent Clin Trials. 2015;10(3):206-11. Review.

PMID:
26238119
15.

PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies.

Black A, Huang WY, Wright P, Riley T, Mabie J, Mathew S, Ragard L, Hermansen S, Yu K, Pinsky P, Prorok PC, Freedman ND, Hoover RN.

Rev Recent Clin Trials. 2015;10(3):238-45. Review.

PMID:
26435289
16.

Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.

Smith RA, Cokkinides V, Brawley OW.

CA Cancer J Clin. 2009 Jan-Feb;59(1):27-41. doi: 10.3322/caac.20008. Review.

18.

Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force.

Humphrey LL, Teutsch S, Johnson M; U.S. Preventive Services Task Force.

Ann Intern Med. 2004 May 4;140(9):740-53. Review.

PMID:
15126259
19.

Screening for cancer: future potential.

Cuzick J.

Eur J Cancer. 1999 May;35(5):685-92. Review.

PMID:
10505025
20.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846

Supplemental Content

Support Center